{"id":"https://openalex.org/W4400901206","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.tps5628","title":"A phase IV trial to confirm the efficacy of olaparib in combination with bevacizumab as maintenance frontline treatment of HRD-positive ovarian tumours (IOlanTHe).","display_name":"A phase IV trial to confirm the efficacy of olaparib in combination with bevacizumab as maintenance frontline treatment of HRD-positive ovarian tumours (IOlanTHe).","publication_year":2024,"publication_date":"2024-06-01","ids":{"openalex":"https://openalex.org/W4400901206","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.tps5628"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2024.42.16_suppl.tps5628","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.tps5628","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1200/jco.2024.42.16_suppl.tps5628","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2024.42.16_suppl.TPS5628","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2024.42.16_suppl.TPS5628","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5072059804","display_name":"Federica Tomao","orcid":"https://orcid.org/0000-0002-9738-3102","observed_orcids":["https://orcid.org/0000-0002-9738-3102"]},"institutions":[{"id":"https://openalex.org/I861853513","display_name":"Sapienza University of Rome","ror":"https://ror.org/02be6w209","country_code":"IT","type":"education","lineage":["https://openalex.org/I861853513"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Federica Tomao","raw_affiliation_strings":["Sapienza University of Rome, Roma, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sapienza University of Rome, Roma, Italy","institution_ids":["https://openalex.org/I861853513"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020635291","display_name":"Lara Paracchini","orcid":"https://orcid.org/0000-0003-1832-5471","observed_orcids":["https://orcid.org/0000-0003-1832-5471"]},"institutions":[{"id":"https://openalex.org/I1339471597","display_name":"Humanitas University","ror":"https://ror.org/020dggs04","country_code":"IT","type":"education","lineage":["https://openalex.org/I1339471597"]},{"id":"https://openalex.org/I4210163047","display_name":"IRCCS Humanitas Research Hospital","ror":"https://ror.org/05d538656","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210163047"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Lara Paracchini","raw_affiliation_strings":["Department of Biomedical Sciences, Humanitas University + IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biomedical Sciences, Humanitas University + IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy","institution_ids":["https://openalex.org/I1339471597","https://openalex.org/I4210163047"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045885701","display_name":"Chiara Battistini","orcid":"https://orcid.org/0000-0003-3583-290X","observed_orcids":["https://orcid.org/0000-0003-3583-290X"]},"institutions":[{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Chiara Battistini","raw_affiliation_strings":["Unit of Gynaecological Oncology Research, European Institute of Oncology IRCCS, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Unit of Gynaecological Oncology Research, European Institute of Oncology IRCCS, Milan, Italy","institution_ids":["https://openalex.org/I6141010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103127347","display_name":"Nicoletta Colombo","orcid":"https://orcid.org/0000-0003-2225-715X","observed_orcids":["https://orcid.org/0000-0003-2225-715X"]},"institutions":[{"id":"https://openalex.org/I189158943","display_name":"University of Milan","ror":"https://ror.org/00wjc7c48","country_code":"IT","type":"education","lineage":["https://openalex.org/I189158943"]},{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Nicoletta Colombo","raw_affiliation_strings":["Department of Medicine and Surgery, University of Milan-Bicocca and Gynecologic Oncology Program, European Institute of Oncology IRCCS, and MANGO, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine and Surgery, University of Milan-Bicocca and Gynecologic Oncology Program, European Institute of Oncology IRCCS, and MANGO, Milan, Italy","institution_ids":["https://openalex.org/I189158943","https://openalex.org/I6141010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068774411","display_name":"Ugo Cavallaro","orcid":"https://orcid.org/0000-0002-0884-6460","observed_orcids":["https://orcid.org/0000-0002-0884-6460"]},"institutions":[{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Ugo Cavallaro","raw_affiliation_strings":["European Institute of Oncology, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"European Institute of Oncology, Milan, Italy","institution_ids":["https://openalex.org/I6141010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060713173","display_name":"Giuseppe Funari","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giuseppe Funari","raw_affiliation_strings":["Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, Italy","institution_ids":["https://openalex.org/I19630809"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017298616","display_name":"Annamaria Ferrero","orcid":"https://orcid.org/0000-0002-2909-3699","observed_orcids":["https://orcid.org/0000-0002-2909-3699"]},"institutions":[{"id":"https://openalex.org/I4210129188","display_name":"A. O. Ordine Mauriziano di Torino","ror":"https://ror.org/03efxpx82","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210129188"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Annamaria Ferrero","raw_affiliation_strings":["Obstetrics and Gynecology Unit ASO Ordine Mauriziano, Torino, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Obstetrics and Gynecology Unit ASO Ordine Mauriziano, Torino, Italy","institution_ids":["https://openalex.org/I4210129188"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027569836","display_name":"Giulia Tasca","orcid":"https://orcid.org/0000-0003-4641-720X","observed_orcids":["https://orcid.org/0000-0003-4641-720X"]},"institutions":[{"id":"https://openalex.org/I4210109345","display_name":"Istituto Oncologico Veneto","ror":"https://ror.org/01xcjmy57","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210109345","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giulia Tasca","raw_affiliation_strings":["Istituto Oncologico Veneto (IRCCS-IOV), Padova, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Oncologico Veneto (IRCCS-IOV), Padova, Italy","institution_ids":["https://openalex.org/I4210109345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033157635","display_name":"Monica Giordano","orcid":"https://orcid.org/0000-0002-8652-3907","observed_orcids":["https://orcid.org/0000-0002-8652-3907"]},"institutions":[{"id":"https://openalex.org/I4210149118","display_name":"Ospedale Sant'Anna","ror":"https://ror.org/04m0kdq23","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210149118"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Monica Giordano","raw_affiliation_strings":["Azienda Ospedaliera Sant'Anna, Como, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Azienda Ospedaliera Sant'Anna, Como, Italy","institution_ids":["https://openalex.org/I4210149118"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038825065","display_name":"Federica Villa","orcid":"https://orcid.org/0009-0005-5052-1079","observed_orcids":["https://orcid.org/0009-0005-5052-1079"]},"institutions":[{"id":"https://openalex.org/I4396570589","display_name":"Aziende Socio Sanitarie Territoriali di Lecco","ror":"https://ror.org/04bmr7q61","country_code":"IT","type":"government","lineage":["https://openalex.org/I4396570589"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Federica Villa","raw_affiliation_strings":["ASST Lecco, Lecco, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ASST Lecco, Lecco, Italy","institution_ids":["https://openalex.org/I4396570589"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050912152","display_name":"Editta Baldini","orcid":"https://orcid.org/0009-0006-6241-346X","observed_orcids":["https://orcid.org/0009-0006-6241-346X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Editta Baldini","raw_affiliation_strings":["Ospedale San Luca, Lucca, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ospedale San Luca, Lucca, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004636457","display_name":"Maria Cristina Petrella","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210115393","display_name":"Azienda Ospedaliero-Universitaria Careggi","ror":"https://ror.org/02crev113","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210115393"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Maria Cristina Petrella","raw_affiliation_strings":["AOU Policlinico Careggi, Florence, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AOU Policlinico Careggi, Florence, Italy","institution_ids":["https://openalex.org/I4210115393"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083501037","display_name":"Elisa Gasparini","orcid":"https://orcid.org/0000-0002-6982-5727","observed_orcids":["https://orcid.org/0000-0002-6982-5727"]},"institutions":[{"id":"https://openalex.org/I4210090508","display_name":"Azienda Sanitaria Unit\u00e0 Locale di Reggio Emilia","ror":"https://ror.org/001bbwj30","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210090508"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Elisa Gasparini","raw_affiliation_strings":["Medical Oncology, Comprehensive Cancer Centre, AUSL-IRCCS di Reggio Emilia, Reggio Emilia, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Comprehensive Cancer Centre, AUSL-IRCCS di Reggio Emilia, Reggio Emilia, Italy","institution_ids":["https://openalex.org/I4210090508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021471647","display_name":"Silvia Derio","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Silvia Derio","raw_affiliation_strings":["European Institute of Oncology (IEO), Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"European Institute of Oncology (IEO), Milan, Italy","institution_ids":["https://openalex.org/I6141010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083910302","display_name":"Fulvio Borella","orcid":"https://orcid.org/0000-0001-8398-7557","observed_orcids":["https://orcid.org/0000-0001-8398-7557"]},"institutions":[{"id":"https://openalex.org/I4210106593","display_name":"Ospedale Sant'Anna","ror":"https://ror.org/010d4kb47","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210086903","https://openalex.org/I4210106593"]},{"id":"https://openalex.org/I55143463","display_name":"University of Turin","ror":"https://ror.org/048tbm396","country_code":"IT","type":"education","lineage":["https://openalex.org/I55143463"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Fulvio Borella","raw_affiliation_strings":["Department of Surgical Science and Gynecology, Azienda Ospedaliero Universitaria, Citt\u00e0 della Salute, presidio S.Anna, Torino, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Surgical Science and Gynecology, Azienda Ospedaliero Universitaria, Citt\u00e0 della Salute, presidio S.Anna, Torino, Italy","institution_ids":["https://openalex.org/I4210106593","https://openalex.org/I55143463"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044906620","display_name":"Maria Francesca Alvisi","orcid":"https://orcid.org/0000-0003-0348-1527","observed_orcids":["https://orcid.org/0000-0003-0348-1527"]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Maria Francesca Alvisi","raw_affiliation_strings":["Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, Italy","institution_ids":["https://openalex.org/I19630809"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109751140","display_name":"Niccol\u00f2 Biagi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Niccol\u00f2 Biagi","raw_affiliation_strings":["Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, Italy","institution_ids":["https://openalex.org/I19630809"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109751141","display_name":"Thu Hoai Dang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Thu Hoai Dang","raw_affiliation_strings":["Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, Italy","institution_ids":["https://openalex.org/I19630809"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069986334","display_name":"Sergio Marchini","orcid":"https://orcid.org/0000-0003-1783-7651","observed_orcids":["https://orcid.org/0000-0003-1783-7651"]},"institutions":[{"id":"https://openalex.org/I1339471597","display_name":"Humanitas University","ror":"https://ror.org/020dggs04","country_code":"IT","type":"education","lineage":["https://openalex.org/I1339471597"]},{"id":"https://openalex.org/I4210163047","display_name":"IRCCS Humanitas Research Hospital","ror":"https://ror.org/05d538656","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210163047"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Sergio Marchini","raw_affiliation_strings":["Department of Biomedical Sciences, Humanitas University + IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biomedical Sciences, Humanitas University + IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy","institution_ids":["https://openalex.org/I1339471597","https://openalex.org/I4210163047"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5052337178","display_name":"Elena Cosenza Biagioli","orcid":"https://orcid.org/0000-0002-2066-3827","observed_orcids":["https://orcid.org/0000-0002-2066-3827"]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Elena Biagioli","raw_affiliation_strings":["Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, Italy","institution_ids":["https://openalex.org/I19630809"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":14,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"42","issue":"16_suppl","first_page":"TPS5628","last_page":"TPS5628"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.002300000051036477,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/olaparib","display_name":"olaparib","score":0.9940000176429749},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":1.0},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.7990000247955322},{"id":"https://openalex.org/keywords/first-line-chemotherapy","display_name":"first-line chemotherapy","score":0.5400000214576721},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.5580000281333923},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.5899999737739563},{"id":"https://openalex.org/keywords/circulating-tumor-dna","display_name":"circulating tumor DNA","score":0.8339999914169312},{"id":"https://openalex.org/keywords/liquid-biopsy","display_name":"liquid biopsy","score":0.8389999866485596},{"id":"https://openalex.org/keywords/translational-biomarkers","display_name":"translational biomarkers","score":0.5950000286102295},{"id":"https://openalex.org/keywords/platinum-based-chemotherapy","display_name":"platinum-based chemotherapy","score":0.4620000123977661},{"id":"https://openalex.org/keywords/translational-research","display_name":"translational research","score":0.43299999833106995},{"id":"https://openalex.org/keywords/fallopian-tube-cancer","display_name":"fallopian tube cancer","score":0.871999979019165},{"id":"https://openalex.org/keywords/peritoneal-cancer","display_name":"peritoneal cancer","score":0.9520000219345093}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9303817749023438},{"id":"https://openalex.org/C2779962180","wikidata":"https://www.wikidata.org/wiki/Q7083106","display_name":"Olaparib","level":5,"score":0.8709648847579956},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.817219614982605},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.6262683868408203},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6261306405067444},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5290511846542358},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.36462467908859253},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3216797113418579},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2683446407318115},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C182979987","wikidata":"https://www.wikidata.org/wiki/Q3907241","display_name":"Poly ADP ribose polymerase","level":4,"score":0.0},{"id":"https://openalex.org/C82381507","wikidata":"https://www.wikidata.org/wiki/Q416878","display_name":"Polymerase","level":3,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1200/jco.2024.42.16_suppl.tps5628","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.tps5628","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1200/jco.2024.42.16_suppl.tps5628","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2024.42.16_suppl.TPS5628","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"pmh:oai:iris.uniroma1.it:11573/1769004","doi":null,"is_oa":false,"landing_page_url":"https://hdl.handle.net/11573/1769004","pdf_url":null,"source":{"id":"https://openalex.org/S4377196107","display_name":"IRIS Research product catalog (Sapienza University of Rome)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1200/jco.2024.42.16_suppl.tps5628","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.tps5628","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1200/jco.2024.42.16_suppl.tps5628","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2024.42.16_suppl.TPS5628","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4400901206.pdf","grobid_xml":"https://content.openalex.org/works/W4400901206.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4241478731","https://openalex.org/W3169132548","https://openalex.org/W2977575205","https://openalex.org/W4310754056","https://openalex.org/W4377115689","https://openalex.org/W4322012149","https://openalex.org/W3087864157","https://openalex.org/W4390078374","https://openalex.org/W4297821473","https://openalex.org/W4322012180"],"abstract_inverted_index":{"TPS5628":[0],"Background:":[1],"PAOLA-1/ENGOT-ov25":[2],"trial":[3,55,118,176,459],"demonstrated":[4],"that":[5,369],"Olaparib":[6],"(O)":[7],"plus":[8,45,160,188],"Bevacizumab":[9],"(B)":[10],"determined":[11],"a":[12,50,68,87,103,211,223,231,238],"significant":[13],"survival":[14,200],"benefit":[15],"in":[16,37,67,79,112,170,206,268,348],"patients":[17,252,428],"(pts)":[18],"with":[19,81,102,181,210,240,281,368,378,426],"advanced,":[20],"high-grade,":[21],"epithelial":[22],"ovarian,":[23],"peritoneal":[24],"and/or":[25],"fallopian-tube":[26],"cancer":[27,371],"(HEOC)":[28],"presenting":[29],"defects":[30],"of":[31,76,107,116,127,135,165,174,202,214,226,234,245,258,272,279,289,301,304,327,335,370,396,407],"homologous":[32],"recombination":[33],"repair":[34],"system":[35],"(HRD+)":[36],"clinical":[38,72,274],"response":[39,365],"after":[40,317],"first-line":[41],"platinum-based":[42],"chemotherapy":[43],"(CT)":[44],"B.":[46,151],"Methods:":[47],"IOLANTHE":[48],"is":[49,436],"multicenter":[51],"Italian":[52],"phase":[53],"IV":[54],"(sponsored":[56],"by":[57,139,374],"the":[58,74,84,113,117,124,132,171,175,195,207,255,259,269,273,302,325,332,352,379,394,397,405,408,424],"MaNGO":[59],"group,":[60],"Protocol":[61],"Number":[62],"IRFMN-OVA-8542)":[63],"aiming":[64,311],"to":[65,71,147,156,236,249,265,285,313,323,330,362,366,439],"confirm":[66],"setting":[69,222],"close":[70],"practice":[73],"efficacy":[75],"this":[77],"combination":[78],"pts":[80,154,216,262,280],"HRD+HEOC.":[82],"As":[83],"study":[85,99,275],"includes":[86],"consistent":[88],"translational":[89,296,356],"component,":[90],"all":[91],"suspicious":[92],"advanced":[93],"cases":[94],"will":[95,109,167,178,229,283,292,299,359,383],"be":[96,110,168,179,266,293,360,384],"considered":[97],"for":[98,131,218,254,393,404,423,444,448,455],"enrollment.":[100],"Pts":[101],"confirmed":[104],"pathological":[105],"diagnosis":[106,326],"HEOC":[108,282],"included":[111],"step":[114,172,256,270],"1":[115,271,298],"which":[119],"main":[120],"inclusion":[121],"criteria":[122],"are":[123,263,421],"following:":[125],"-availability":[126],"formalin-fixed,":[128],"paraffin-embedded":[129],"samples":[130],"central":[133],"testing":[134],"HRD":[136],"status":[137,334],"(performed":[138],"Myriad":[140],"Mychoice":[141],"CDx":[142],"Plus":[143],"assay)":[144],"-":[145,312,322,329],"suitability":[146],"receive":[148],"CT":[149,159,286,451],"+":[150],"Only":[152],"HRD+":[153],"responding":[155],"first":[157],"line":[158],"at":[161],"least":[162],"one":[163],"cycle":[164],"B":[166,182],"enrolled":[169,267],"2":[173,257,358],"and":[177,221,287,319,338,390,400,411,418,430,450,452],"treated":[180,377],"15":[183],"mg/kg":[184],"every":[185],"3":[186,431],"weeks":[187],"O":[189],"300":[190],"mg":[191],"twice":[192],"daily.":[193],"Considering":[194],"PAOLA-1":[196],"median":[197],"progression":[198,328],"free":[199],"(PFS)":[201],"37.2":[203],"months":[204,220,443,447,454],"(mo)":[205],"B-O":[208],"arm,":[209],"sample":[212],"size":[213],"90":[215,251],"followed":[217],"24":[219,453],"one-side":[224],"error":[225],"5%,":[227],"we":[228],"have":[230,250,415],"statistical":[232],"power":[233],"80%":[235,278],"demonstrate":[237],"PFS-24mo\u226564%":[239],"an":[241],"upper":[242],"critical":[243],"value":[244],"61%.":[246],"In":[247],"order":[248],"eligible":[253],"study,":[260],"190":[261],"needed":[264],"(as":[276],"approximately":[277],"respond":[284],"out":[288],"these,":[290],"60%":[291],"HRD+).":[294],"The":[295,355,434],"subproject":[297,357],"consist":[300],"analysis":[303],"circulating-tumor":[305],"(ctDNA),":[306],"using":[307,386],"whole":[308],"genome":[309],"sequencing":[310],"correlate":[314],"residual":[315],"tumour":[316],"surgery":[318,449],"ctDNA":[320],"levels":[321],"anticipate":[324],"monitor":[331],"mutational":[333],"HR-related":[336],"genes":[337,340],"other":[339,419],"such":[341],"as":[342],"Tp53BP1,":[343],"POLQ,":[344],"REV7":[345],"probably":[346],"involved":[347],"PARPi":[349],"resistance":[350],"during":[351],"maintenance":[353,456],"therapy.":[354],"developed":[361],"compare":[363],"pts\u2019":[364],"therapy":[367],"cells,":[372],"tested":[373],"organotypic":[375],"model":[376],"combination.":[380],"These":[381],"models":[382],"generated":[385],"fresh":[387],"tumor":[388,398],"tissue":[389],"ascitic":[391],"fluid":[392],"isolation":[395,406],"cells":[399,410],"macroscopically":[401],"healthy":[402],"omentum":[403],"mesothelial":[409],"fibroblasts.":[412],"Eight":[413],"centers":[414],"been":[416],"activated":[417],"6":[420,446],"waiting":[422],"activation":[425],"19":[427],"registered":[429],"screening":[432],"failures.":[433],"enrollment":[435],"continuing,":[437],"according":[438],"protocol":[440],"timeline":[441],"(12":[442],"enrollment,":[445],"treatment).":[457],"Clinical":[458],"information:":[460],"NCT06121401":[461],".":[462]},"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2024-07-24T00:00:00"}